InformationWeek's annual "Elite 100" corporate list for innovative technology includes several located in or have big operations around the Triangle as well as the City of Asheville.
The Elite 100
June 9, 2014
Merck said Monday it would buy Idenix Pharmaceuticals for $3.85 billion and plans to combine the company's two most promising drugs to produce a faster, more effective cure for hepatitis C.
February 4, 2014
Data generated from the work will be made public for other scientists to use, a move that the U.S. National Institutes of Health called groundbreaking. The targeted diseases are some of the most prevalent conditions among Americans, costing the nation billions of dollars in treatment and lost productivity.
January 9, 2014
Novartis reportedly is in negotiations with fellow drug giant Merck about a $10 billion asset swap that would include the Novartis human vaccines and animal health businesses. Novartis operates a huge vaccine in Holly Springs and is building an R&D center in RTP.
Novartis plant in Holly Springs
October 28, 2013
Merck the second-biggest U.S. drugmaker which operates a huge facility in Durham, narrowed its full-year forecast after sales of its top-seller, diabetes pill Januvia, declined.
October 1, 2013
The second largest U.S. drug maker, which has a large vaccine plant operation in Durham, is cutting thousands of jobs and consolidating its headquarters in New Jersey.
May 9, 2013
Two drug giants with substantial operations in North Carolina are drastically cutting the costs of their cervical cancer vaccines as part of the first large-scale effort to get the shots to girls in the world's poorest areas.
Updated February 15, 2013
February 15, 2013
The deal settles two long-running lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop in sales.
Updated December 10, 2012
Finding the right chemistry is crucial to biotech deals, as two major life science partnerships in the Triangle have shown this year: GSK and Liquidia; Merck and Chimerix.
July 25, 2012
In exchange for exclusive worldwide license and funding the drug development and commercialization costs, Merck will pay Chimerix $17.5 million on top of royalties on future sales and milestone payments of up to $151 million.
May 2, 2012
Drug giant Merck will invest $15 million to update and expand its facility in Wilson. However, no new jobs are planned, the Wilson Times reports.
October 10, 2011
The drug giant also receives approval from the FDA for a drug that treats type 2 diabetes and cholesterol problems.
June 30, 2011
The drug giant recently purchased Raleigh-based Inspire Pharmaceuticals. In a notice filed with the state, the expected closure of Inspire's offices is made official.
May 17, 2011
Some company executives will be leaving the eye drug firm as it is absorbed by the pharmaceutical giant.
November 30, 2010
Richard Clark will remain chairman of the drug giant when Kenneth Frazier assumes CEO role. Merck operates a vaccine manufacturing plant in Durham.
November 29, 2010
Merck drug also receives support, but reviewers express concern about the overall benefits of the drugs.
November 17, 2010
An experimental Merck drug safely boosted good cholesterol to record highs while dropping bad cholesterol to unprecedented lows in a study that stunned researchers and renewed hopes for an entirely new way of lowering heart risks.
May 4, 2010
The drug giants, which are growing their presence in the Research Triangle region, say first-quarter sales were strong. Wyeth acquisition boosts Pfizer. But Schering-Plough acquisition costs hurt Merck profits.
Updated November 4, 2009
The two pharma giants completed the deal after the markets closed Tuesday, and the new Merck moved up from being the No. 8 drugmaker. creating the No. 2 drug-maker